Q2 EPS Estimate for OnKure Therapeutics Increased by Analyst
OnKure Therapeutics (NASDAQ:OKUR – Free Report) – Research analysts at Leerink Partnrs boosted their Q2 2025 EPS estimates for shares of OnKure Therapeutics in a research note issued on Tuesday, May 6th. Leerink Partnrs analyst A. Berens now anticipates that the company will post earnings per share of ($1.21) for the quarter, up from their […]
OnKure Therapeutics (NASDAQ:OKUR – Free Report) – Research analysts at Leerink Partnrs boosted their Q2 2025 EPS estimates for shares of OnKure Therapeutics in a research note issued on Tuesday, May 6th. Leerink Partnrs analyst A. Berens now anticipates that the company will post earnings per share of ($1.21) for the quarter, up from their […]
